Topical Steroids

Which Medications Are Prescribed Most Often for Atopic Dermatitis?

By August 10, 2017

Male patients exhibited the highest rates of oral steroid prescriptions.

Topical System Tx Suggests Improved Healing Post-Laser Resurfacing

April 13, 2017

The researchers found that blinded investigator-rated healing was better for the tripeptide/hexapeptide system, with the difference reaching statistical significance at day 7.

Review of Moisturizer Efficacy in Eczema

By February 09, 2017

Among patients with eczema, most moisturizers showed some benefit but better results were seen when used with topical active treatment, according to a Cochrane Review.

Antifungal and Retinoid Combo Displays Anti-Aging Benefits

January 26, 2017

Climbazole enhances retinoid-associated biological activities in vivo and in vitro, according to a study published online January 19 in the International Journal of Cosmetic Science.

Topical Steroid Tridesilon Now Available

By January 18, 2017

Tridesilon (desonide) Cream, 0.05%, has been made available by Encore Dermatology. This low-potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Teva Launches Generic Topicort Ointment

By November 30, 2016

Teva announced the launch of Desoximetasone Ointment, the generic version of Taro's Topicort Ointment.

Wet Wrap Therapy for Atopic Dermatitis: Is It Effective?

November 14, 2016

Wet wrap therapy may pose higher risk of local infections than topical steroids

Teligent Approved for Triamcinolone Acetonide Ointment

By May 16, 2016

Teligent Approved for Triamcinolone Acetonide Ointment

Preventive Use of Topical Steroids Controls Atopic Dermatitis Severity

April 28, 2016

May also prevent an increase in aeroallergen-specific IgE levels

ANI Launches Hydrocortisone Rectal Cream

By April 05, 2016

ANI announced the launch of Hydrocortisone Cream for Rectal Use.

Clinical Rebounding Triad After Corticosteroid Discontinuation

July 08, 2015

A subgroup of patients with dermatitis who discontinue topical corticosteroids (TC) after long-term treatment have clinical rebounding triad manifestations.

Perrigo Launches Generic Kenalog Spray

By April 16, 2015

Perrigo announced the launch of Triamcinolone Acetonide Topical Aerosol, the generic version of Sun Pharma's Kenalog spray.

Adding BP Drug May Lessen Topical Steroid Side Effects

By March 18, 2015

An antihypertensive was found to reduce side effects from corticosteroid-based creams used for certain skin diseases, reports a study published in the Journal of Investigative Dermatology.

Generic Temovate Launched by Actavis

By March 09, 2015

Actavis announced the launch of Clobetasol Propionate Cream 0.05%, the generic version of Fougera's Temovate.

Perrigo Launches Generic Clobex Spray

By January 12, 2015

Perrigo announced the launch of Clobetasol Propionate Spray 0.05% , the generic version of Galderma's Clobex Spray.

New Dermatoses Ointment Launched

June 30, 2014

Aqua Pharmaceuticals announced the launch of Cordran Ointment (flurandrenolide) 0.05% for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Teledermatology Is Reliable for Initial Triage Consultations

February 18, 2014

Teledermatology is reliable for initial triage of patients, according to a study published online.

Perrigo Launches Generic Vanos Cream

January 14, 2014

Perrigo announced it has received final approval for its abbreviated New Drug Application (ANDA) for Fluocinonide Cream 0.1%, the generic version of Medicis' Vanos Cream.

Derma-Smoothe/FS Scalp and Body Oil Generics Approved

August 12, 2013

Perrigo has received approval from the FDA for Fluocinolone Acetonide Scalp Oil, 0.01% and Fluocinolone Acetonide Topical Oil 0.01%, the generic equivalents to Derma-Smoothe/FS Scalp and Body Oil, respectively.

Topicort Spray Approved to Treat Plaque Psoriasis

April 15, 2013

Taro Pharmaceuticals has received FDA approval for its New Drug Application for Topicort Topical Spray, a corticosteroid indicated for the treatment of plaque psoriasis in patients 18 years and older.

Perrigo Launches Generic Luxiq Foam

January 15, 2013

Perrigo announced it has begun commercial shipments of Betamethasone Valerate Foam 0.12%, the generic version of Stiefel Laboratories' Luxiq Foam.

Perrigo Approved for Generic Luxiq Foam

November 28, 2012

Perrigo announced that its partner, Cobrek Pharmaceuticals, received final approval from the FDA for its Abbreviated New Drug Application (ANDA) for Betamethasone Valerate Foam 0.12%, the generic version Stiefel Laboratories' Luxiq Foam.

Delays in Diagnosis, Variations in Treatment for Morphea

October 17, 2012

Patients with localized scleroderma (morphea) often experience delay in diagnosis and variability in treatment that is based more on the specialty of the provider than disease characteristics.

Topical Corticosteroids Impair Restoration of Skin Barrier

February 16, 2012

Topical corticosteroids offer a more potent anti-inflammatory effect for the treatment of atopic dermatitis (AD), but they may impair the restoration of the skin barrier and can induce skin atrophy, making topical calcineurin inhibitors more suitable for long-term treatment of the disease.

Tentative Approval of Clobetasol Propionate Emulsion Foam

October 06, 2011

Perrigo Company announced that it received tentative approval of its Abbreviated New Drug Application (ANDA) for clobetasol propionate emulsion foam, 0.05%.